Posaconazole Tablet, Delayed Release
Product Images NDC 70377-038

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 70377-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Phama Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60-tab-label (60 Tab Label)

The label for POSACONAZOLE Delayed-Release Tablets contains 100 mg of posaconazole per tablet. It states dosage form as delayed-release tablets, oral route, with a package size of 60 tablets. Manufactured by Biocon Pharma Limited, Bengaluru, India, and labeled for Biocon Pharma Inc., Iselin, NJ, USA. The label includes storage instructions and a barcode.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Posaconazole, the active ingredient in POSACONAZOLE delayed-release oral tablets, 100 mg by Biocon Pharma Inc. The diagram depicts the specific molecular bonds and arrangement of atoms characteristic of Posaconazole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.